244 results on '"Orth‐Höller, Dorothea"'
Search Results
2. Genetic determinants of complement activation in the general population
3. Xanthoepocin, a photolabile antibiotic of Penicillium ochrochloron CBS 123823 with high activity against multiresistant gram-positive bacteria
4. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
5. Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action
6. Initial Evidence of Distinguishable Bacterial and Fungal Dysbiosis in the Skin of Patients with Atopic Dermatitis or Netherton Syndrome
7. A high leukocyte count and administration of hydrocortisone hamper PCR-based diagnostics for bloodstream infections
8. Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth
9. Complement C7 and clusterin form a complex in circulation
10. Detection of Cleaved Stx2a in the Blood of STEC-Infected Patients
11. Shiga toxin 2a binds antithrombin and heparin, but does not directly activate platelets
12. Pooled saliva samples as an approach to reduce the spread of infections with SARS-CoV-2
13. Enzymatic Cleavage of Stx2a in the Gut and Identification of Pancreatic Elastase and Trypsin as Possible Main Cleavers
14. 176 A genome-wide association screening of complement activation from a general population study
15. 181 Complement C7 and clusterin form a stable complex in circulation
16. The genetics of atypical hemolytic uremic syndrome
17. A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria
18. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations
19. Influence of antibiotic treatment on the detection of S. aureus in whole blood following pathogen enrichment
20. “Enhanced acquisition of antibiotic-resistant intestinal E. coli during the first year of life assessed in a prospective cohort study”
21. Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients
22. Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience
23. Comparison of rapid hybridization-based pathogen identification and resistance evaluation in sepsis using the Verigene® device paired with “good old culture”
24. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family
25. Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit
26. Enterohemorrhagic Escherichia coli O26:H11/H − : A New Virulent Clone Emerges in Europe
27. Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli—Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae
28. Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection
29. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study
30. Genetic characterization of Panton–Valentine leukocidin-producing methicillin-resistant Staphylococcus aureus in Western Austria
31. Treatment of Enterohemorrhagic Escherichia coli-Induced Hemolytic Uremic Syndrome (eHUS)
32. An Update on the Thrombotic Microangiopathies Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP)
33. Role of Complement in Enterohemorrhagic Escherichia coli-Induced Hemolytic Uremic Syndrome
34. Genomic and Phenotypic Analysis of Linezolid-Resistant Staphylococcus epidermidis in a Tertiary Hospital in Innsbruck, Austria
35. Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines
36. Inhibition of terminal complement activation in severe Shiga toxin‐associated HUS – perfect example for a fast track from bench to bedside
37. Method for the Detection of the Cleaved Form of Shiga Toxin 2a Added to Normal Human Serum
38. Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines
39. Human adenoviruses associated with respiratory illness in neonates, infants, and children in the Sousse area of Tunisia
40. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells
41. Successful treatment of a unique chronic multi-bacterial scalp infection with N-chlorotaurine, N-bromotaurine and bromamine T
42. Long-sleeved medical workers' coats and their microbiota
43. Candida albicans Factor H Binding Molecule Hgt1p – A Low Glucose-Induced Transmembrane Protein Is Trafficked to the Cell Wall and Impairs Phagocytosis and Killing by Human Neutrophils
44. Additional file 1: of 'Enhanced acquisition of antibiotic-resistant intestinal E. coli during the first year of life assessed in a prospective cohort study'
45. Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection
46. Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006-2015): Impacts & trends
47. Pathogen enrichment from human whole blood for the diagnosis of bloodstream infection: Prospects and limitations
48. Antibody opsonization enhancesMAITcell responsiveness to bacteria via aTNF‐dependent mechanism
49. The structure of the Shiga toxin 2a A‐subunit dictates the interactions of the toxin with blood components
50. High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.